Vascular Neurology Considerations for Anti-Amyloid Immunotherapy

You are currently not logged in to PHD

To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of membership benefits, join or renew today!  

Please note: AHA does not associate with, nor endorse YouTube recommendations.

Vascular Neurology Considerations for Anti-Amyloid Immunotherapy
Authors Mark Fisher, MD and Steve Greenberg, MD announce the publication of the science advisory in the journal STROKE and discuss predictors of ARIA, the use of antithrombotic and thrombolytic medications in patients receiving anti-amyloid therapy, and suggested treatment approaches.
Recommended Videos
saved video
Save Video

Please note: AHA does not associate with, nor endorse YouTube recommendations.

Video is not available. Please check the URL.